1
|
Colombo D, Rigoni C, Cantù A, Carnevali A, Filippetti R, Franco T, Grassi A, Loi C, Mazzotta A, Patroi I, Raone B, Tomassini MA, Amoruso A, Pane M, Damiani G. Probiotics and Prebiotics Orally Assumed as Disease Modifiers for Stable Mild Atopic Dermatitis: An Italian Real-Life, Multicenter, Retrospective, Observational Study. MEDICINA (KAUNAS, LITHUANIA) 2023; 59:2080. [PMID: 38138183 PMCID: PMC10744411 DOI: 10.3390/medicina59122080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/02/2023] [Revised: 11/16/2023] [Accepted: 11/17/2023] [Indexed: 12/24/2023]
Abstract
The role of the skin-gut axis in atopic dermatitis (AD) remains a subject of debate, limiting non-pharmacological interventions such as probiotics and prebiotics. To improve understanding of their potential as a monotherapy for stable mild cases, we conducted a real-life, multicenter, retrospective observational study in Italy. We administered three selected bacteria (Bifidobacterium animalis subsp. lactis BS01, Lactiplantibacillus plantarum LP14, and Lacticaseibacillus rhamnosus LR05) orally to patients with mild atopic dermatitis without a placebo control group, following up for 12 weeks. Clinical assessments using the Scoring Atopic Dermatitis (SCORAD), Eczema Area and Severity Index (EASI), and Three-Item Severity (TIS) score were conducted on 144 enrolled patients (average age: 25.1 ± 17.6 years). Notably, both pruritus and AD-related lesions (erythema, edema/papules, excoriation) exhibited significant clinical and statistical improvement (p < 0.001) after 12 weeks of exclusive probiotic and prebiotic use. These preliminary results suggest a potential link between the skin-gut microbiome and support the rationale for using specific probiotics and prebiotics in mild AD, even for maintenance, to reduce flares and dysbiosis.
Collapse
Affiliation(s)
- Delia Colombo
- Independent Researcher, Private Practice, Via Livigno 6, 20158 Milan, Italy;
| | - Corinna Rigoni
- Independent Researcher, Private Practice, Corso Monteforte 40, 20122 Milan, Italy;
| | - Alessandra Cantù
- Independent Researcher, Private Practice, Via Domodossola 9/A, 20145 Milan, Italy;
| | - Antonello Carnevali
- Independent Researcher, Private Practice, Str. Colomba Pecorari 32/a, 06134 Perugia, Italy;
| | | | - Tiziana Franco
- Independent Researcher, Private Practice, Viao Veio, 04100 Latina, Italy;
| | - Alessandra Grassi
- Independent Researcher, Private Practice, Via Coletti 19, 00191 Rome, Italy;
| | - Camilla Loi
- Independent Researcher, Private Practice, Via X Settembre 1943 7 and 9, 40011 Anzola dell’Emilia, Italy;
| | - Annamaria Mazzotta
- Independent Researcher, Private Practice, Viale di Villa Massimo 48, 00161 Rome, Italy;
| | - Ivona Patroi
- Independent Researcher, Private Practice, Via del Tritone 102, 00187 Rome, Italy;
| | - Beatrice Raone
- Independent Researcher, Private Practice, Via Ruggero Leoncavallo 5, 40137 Bologna, Italy;
| | | | - Angela Amoruso
- Independent Researcher, Probiotical Research srl, Via Mattei 3, 28100 Novara, Italy; (A.A.); (M.P.)
| | - Marco Pane
- Independent Researcher, Probiotical Research srl, Via Mattei 3, 28100 Novara, Italy; (A.A.); (M.P.)
| | - Giovanni Damiani
- Department of Biomedical, Surgical and Dental Sciences University of Milan, 20122 Milan, Italy
- Department of Pharmaceutical and Pharmacological Sciences, PhD Degree Program in Pharmacological Sciences, University of Padua, 35122 Padua, Italy
| |
Collapse
|